QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

OCGN

QT34Ocugen, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
1.24
+0.01+0.81%
OverviewShort InterestFilings
OCGNQT34Ocugen, Inc.·NASDAQ
OverviewShort InterestFilings
1.24+0.81%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.22
Insider Own8.31%
Shs Outstand338.52M
Perf Week1.64%
Market Cap416.38MForward P/E-EPS next Y-0.24Insider Trans0.12%Shs Float-Perf Month-4.62%
Enterprise Value417.82MPEG0.30EPS next Q-0.05Inst Own-Short Float-Perf Quarter-44.64%
Income-75739865.00P/S93.25EPS this Y-2.60%Inst Trans-Short Ratio-Perf Half Y-16.22%
Sales4.46MP/B67.89EPS next Y-7.22%ROA-125.95%Short Interest-Perf YTD-8.15%
Book/sh0.02P/C-EPS next 5Y-ROE-127987.50%52W High2.73 -54.58%Perf Year13.76%
Cash/sh0.09P/FCF-EPS past 3/5Y-ROIC-157.55%52W Low0.90 37.34%Perf 3Y-
Dividend Est.-EV/EBITDA-6.51Sales past 3/5Y25.99% -Gross Margin100.00%Volatility4.65% 3.71%Perf 5Y-
Dividend TTM-EV/Sales93.58EPS Y/Y TTM-20.00%Oper. Margin-1483.85%ATR (14)0.08Perf 10Y-
Dividend Ex-Date-Quick Ratio1.86Sales Y/Y TTM25.00%Profit Margin-1605.22%RSI (14)39.84Recom2.17
Dividend Gr. 3/5Y-Current Ratio1.86EPS Q/Q-20.00%SMA20-4.06%Beta1.52Target Price5.00
Payout0.00%Debt/Eq5.74Sales Q/Q100.00%SMA50-17.51%Rel Volume3.74Prev Close1.23
Employees95LT Debt/Eq-2.58EarningsJul 30SMA200-19.02%Avg Volume7.02MPrice1.24
IPO DateDec 03, 2014Option/ShortNo / YesEPS/Sales Surpr.-20.00% -Net Debt/EBITDA-0.02Volume26,248,815Change0.81%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-01-23UpgradeChardan CapitalNeutral → Buy
Aug-23-22InitiatedMizuhoBuy$5.00
Aug-15-22ReiteratedH.C. Wainwright$6.00
Jun-18-22ReiteratedCantor FitzgeraldNeutral$4.50
May-08-22ReiteratedChardan CapitalNeutral$3.50
Apr-25-22ReiteratedRoth CapitalNeutral$6.00
Jun-11-21DowngradeRoth CapitalBuy → Neutral
May-07-21DowngradeCantor FitzgeraldOverweight → Neutral
Feb-09-21DowngradeChardan CapitalBuy → Neutral
Feb-04-21UpgradeHC Wainwright & Co.Neutral → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue544
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A022
Gross Profit522
Selling, General and Administrative Excl. Other272827
Research and Development374032
Other Operating Expense1-3-2
Operating Income-61-63-55
Interest Expense350
Unusual Expense
———
Non-Operating Income (Expense)10-1
Net Income Before Taxes-64-68-54
Income Taxes000
Consolidated Net Income-64-68-54
Net Income From Continuing Operations-64-68-54
Net Income-64-68-54
EPS (Recurring)-0.22-0.23-0.20
EPS (Basic, Before Extraordinaries)-0.22-0.23-0.20
EPS (Diluted)-0.22-0.23-0.20
EBITDA-58-60-52
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio75.39101.25—
Gross Margin100.0050.0050.00
Operating Margin-1,220.00-1,575.00-1,375.00
Net Margin-1,280.00-1,700.00-1,350.00
Shares Outstanding304300271
Market Capitalization377405—
Operating Lease Expense
———
Insider Trading Volume
$1.40$1.30$1.20$1.09$0.99● Close Price0.00K6.46K12.91K19.37K25.83KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Johnson-Greene Treerita EssalimaChief Financial OfficerJun 15 '26Buy1.2321,00025,830521,000Jun 17 12:00 AM
Zhang JungeDirectorApr 01 '26Option Exercise0.79388,268308,6061,359,316Apr 02 12:00 AM
Fernandes PrabhavathiDirectorNov 26 '24Buy0.9110,0009,09510,000Dec 02 12:00 AM
Castillo KirstenDirectorNov 22 '24Buy0.9125,00022,84875,000Nov 26 12:00 AM
Zhang JungeDirectorJun 14 '23Buy0.50200,27899,9991,077,182Jun 16 12:00 AM
Musunuri ShankarChief Executive OfficerFeb 16 '23Sale1.08100,000108,0002,190,073Feb 17 12:00 AM
Musunuri ShankarChief Executive OfficerFeb 16 '23Option Exercise0.33200,00066,0002,290,073Feb 17 12:00 AM
Musunuri ShankarChief Executive OfficerJan 17 '23Sale1.28100,000128,0002,227,950Jan 19 12:00 AM
Musunuri ShankarChief Executive OfficerJan 17 '23Option Exercise0.26200,00051,0002,327,950Jan 19 12:00 AM
Musunuri ShankarChief Executive OfficerDec 16 '22Option Exercise0.26191,61848,863848,349Dec 20 12:00 AM
Musunuri ShankarChief Executive OfficerDec 16 '22Sale1.4395,809137,007752,540Dec 20 12:00 AM
Musunuri ShankarChief Executive OfficerOct 14 '22Option Exercise0.26200,00051,000852,540Oct 14 12:00 AM
Musunuri ShankarChief Executive OfficerOct 14 '22Sale1.66100,000166,000752,540Oct 14 12:00 AM
Kumar RameshDirectorOct 06 '22Option Exercise0.514,5002,2954,500Oct 07 12:00 AM
Kumar RameshDirectorOct 06 '22Sale1.834,5008,2350Oct 07 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR